190 related articles for article (PubMed ID: 31292541)
21. Characterization of a novel tumorigenic esophageal adenocarcinoma cell line: OANC1.
Clemons NJ; Do H; Fennell C; Deb S; Fellowes A; Dobrovic A; Phillips WA
Dig Dis Sci; 2014 Jan; 59(1):78-88. PubMed ID: 24077944
[TBL] [Abstract][Full Text] [Related]
22. Histopathological features of the gastroesophageal junction: an Eastern view.
Kim A; Shin N; Lee HJ; Jo HJ; Kim JY; Kim YK; Park DY; Park WY; I H; Kim GH
Histol Histopathol; 2015 Jun; 30(6):689-95. PubMed ID: 25236753
[TBL] [Abstract][Full Text] [Related]
23. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690
[TBL] [Abstract][Full Text] [Related]
24. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
[TBL] [Abstract][Full Text] [Related]
25. Staging of adenocarcinoma of the gastroesophageal junction.
Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.
Bonde P; Sui G; Dhara S; Wang J; Broor A; Kim IF; Wiley JE; Marti G; Duncan M; Jaffee E; Montgomery E; Maitra A; Harmon JW
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):763-9. PubMed ID: 17320581
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinoma of the GEJ: gastric or oesophageal cancer?
Rüschoff J
Recent Results Cancer Res; 2012; 196():107-13. PubMed ID: 23129369
[TBL] [Abstract][Full Text] [Related]
28. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
[TBL] [Abstract][Full Text] [Related]
29. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
30. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.
Fichtner I; Rolff J; Soong R; Hoffmann J; Hammer S; Sommer A; Becker M; Merk J
Clin Cancer Res; 2008 Oct; 14(20):6456-68. PubMed ID: 18927285
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery.
Zhang J; Jiang D; Li X; Lv J; Xie L; Zheng L; Gavine PR; Hu Q; Shi Y; Tan L; Ge D; Xu S; Li L; Zhu L; Hou Y; Wang Q
Lab Invest; 2014 Aug; 94(8):917-26. PubMed ID: 24999713
[TBL] [Abstract][Full Text] [Related]
32. What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer.
Mullen JT; Kwak EL; Hong TS
Ann Surg Oncol; 2016 Nov; 23(12):3780-3785. PubMed ID: 27459983
[TBL] [Abstract][Full Text] [Related]
33. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma.
Dong H; Guo H; Xie L; Wang G; Zhong X; Khoury T; Tan D; Zhang H
PLoS One; 2013; 8(5):e62986. PubMed ID: 23671646
[TBL] [Abstract][Full Text] [Related]
34. Nivolumab in gastric/gastroesophageal junction cancer: real-world data from UK Early Access to Medicines Scheme.
Soni M; Kiff C; Carroll R; Stein D; Saragoussi D; Nassar A; Maisey N; Tyas D
Future Oncol; 2021 Aug; 17(24):3163-3174. PubMed ID: 34098737
[TBL] [Abstract][Full Text] [Related]
35. Growth of carcinoma of the esophagus and gastroesophageal junction in a human tumor cloning assay.
Harris GJ; Turner JN; Von Hoff DD
Cancer Drug Deliv; 1986; 3(4):273-8. PubMed ID: 3567847
[TBL] [Abstract][Full Text] [Related]
36. Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.
Apicella M; Migliore C; Capelôa T; Menegon S; Cargnelutti M; Degiuli M; Sapino A; Sottile A; Sarotto I; Casorzo L; Cassoni P; De Simone M; Comoglio PM; Marsoni S; Corso S; Giordano S
Oncogene; 2017 Mar; 36(9):1200-1210. PubMed ID: 27524418
[TBL] [Abstract][Full Text] [Related]
37. Multi-modality therapy for cancer of the esophagus and GE junction.
Tejani MA; Burtness BA
Curr Treat Options Oncol; 2012 Sep; 13(3):390-402. PubMed ID: 22592595
[TBL] [Abstract][Full Text] [Related]
38. Xenograft tumors derived from malignant pleural effusion of the patients with non-small-cell lung cancer as models to explore drug resistance.
Xu Y; Zhang F; Pan X; Wang G; Zhu L; Zhang J; Wen D; Lu S
Cancer Commun (Lond); 2018 May; 38(1):19. PubMed ID: 29764505
[TBL] [Abstract][Full Text] [Related]
39. Unanswered questions in the management of gastroesophageal junction adenocarcinoma: an overview from the medical oncologist's perspective.
Shah MA
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714486
[TBL] [Abstract][Full Text] [Related]
40. Prognostic importance and therapeutic implications of PAK1, a drugable protein kinase, in gastroesophageal junction adenocarcinoma.
Li Z; Zou X; Xie L; Dong H; Chen Y; Liu Q; Wu X; Zhou D; Tan D; Zhang H
PLoS One; 2013; 8(11):e80665. PubMed ID: 24236193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
